OZAFY
Dead / Abandoned — Abandoned — no statement of use filed (as of 03 Apr 2023)
What this means for you
This application is over — abandoned 03 Apr 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90482421
- Mark type
- Stylized text
- Filed
- 22 Jan 2021
- Published for opposition
- 07 Sept 2021
- Abandoned
- 03 Apr 2023
- Attorney of record
- Frances M. Jagla
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, autoimmune disorders, inflammatory disorders and treatment and prevention of graft/host disorders
- Class 044 — Medical, beauty and agricultural services: Providing healthcare information
Owner
- CTI Biopharma Corp., Seattle, WA, US
- CTI Biopharma Corp., Seattle, WA, US
Prosecution history
- 03 Apr 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 03 Apr 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Aug 2022 — SOU EXTENSION 1 GRANTED
- 16 Aug 2022 — SOU EXTENSION 1 FILED
- 16 Aug 2022 — SOU TEAS EXTENSION RECEIVED
- 01 Mar 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Jan 2022 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 06 Oct 2021 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 07 Sept 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Sept 2021 — PUBLISHED FOR OPPOSITION
- 18 Aug 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Aug 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Aug 2021 — ASSIGNED TO EXAMINER
- 23 Apr 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED